Kazakhstan vs Latvia: Cause of death, by non-communicable diseases, ages 5-14, male
Kazakhstan
35.4%
in 2021
Latvia
35.8%
in 2021
Kazakhstan rank
91st
Latvia rank
88th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Kazakhstan
- Latvia
How they compare
Latvia currently reports 35.8% against 35.4% in Kazakhstan, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Latvia ahead.
Kazakhstan ranks 91st and Latvia ranks 88th of 185 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Kazakhstan | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.1% | 33.4% | 3.4% | Latvia |
| 2010s | 35.1% | 49.6% | 14.4% | Latvia |
| 2020s | 36.9% | 35.1% | 1.7% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Kazakhstan or Latvia?
- Latvia, at 35.8% against 35.4% in Kazakhstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Kazakhstan and Latvia?
- 0.4%, with Latvia ahead.
- How many years of comparable data are there for Kazakhstan and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Latvia rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Kazakhstan ranks 91st and Latvia ranks 88th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.